Your browser doesn't support javascript.
loading
Targeting the FGFR Pathway in Urothelial Carcinoma: the Future Is Now.
Peng, Jenny; Sridhar, Srikala; Siefker-Radtke, Arlene Odelia; Selvarajah, Shamini; Jiang, Di Maria.
  • Peng J; Division of Medical Oncology, Department of Medicine, Princess Margaret Cancer Centre, University Health Network, 7-613, 700 University Avenue, Toronto, ON, M5G 2C1, Canada.
  • Sridhar S; Division of Medical Oncology, Department of Medicine, Princess Margaret Cancer Centre, University Health Network, 7-613, 700 University Avenue, Toronto, ON, M5G 2C1, Canada.
  • Siefker-Radtke AO; Division of Medical Oncology, Department of Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Selvarajah S; Clinical Laboratory Genetics, Laboratory Medicine Program, University Health Network (UHN), Toronto General Hospital, Eaton Wing 11-444, 200 Elizabeth Street, Toronto, ON, Canada.
  • Jiang DM; Department of Laboratory Medicine and Pathobiology, University of Toronto, 1 King's College Circle, 6th Floor, Toronto, ON, Canada.
Curr Treat Options Oncol ; 23(9): 1269-1287, 2022 09.
Article en En | MEDLINE | ID: mdl-35962938

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Vejiga Urinaria / Carcinoma de Células Transicionales Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Vejiga Urinaria / Carcinoma de Células Transicionales Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article